Avalide

Let’s talk about Avalide. In my practice, managing hypertension often feels like a delicate balancing act—juggling efficacy, side effects, patient adherence, and the ever-present concern for end-organ protection. When I first started, the pill burden was a real problem. You’d start with a thiazide, see some response, but not enough, then add an ARB, and suddenly the patient is on two pills, maybe at different times, and adherence starts to slip.